Auravax Therapeutics
About Auravax Therapeutics
AuraVax is a biopharmaceutical company that specializes in developing treatments and prevention for upper respiratory disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $253.2K
- Last round: Grant (Sep 2025)
- Website: auravax.com
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/auravax-therapeutics-7584 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.